Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term Drug Molecules refers to a broad category of chemical or biological substances used for medical therapy, rather than a specific biological target such as a receptor or enzyme. According to the U.S. Food and Drug Administration (FDA), a drug is defined as a substance intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease (FDA, 2023). In contrast, a drug target is a specific molecular entity, typically a protein, whose activity is modified by a drug to produce a therapeutic effect (IUPAC, 1997). Because Drug Molecules is a collective noun for the agents of therapy, it cannot be classified as a therapeutic target itself. This entry is considered incorrect for target identification purposes as it lacks the biological specificity required to define a mechanism of action or a role in disease pathology. Specificity is essential in drug discovery to link a molecule to a particular biological pathway or clinical outcome.
Not applicable as this term refers to the therapeutic agents themselves rather than a biological target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Drug Molecules.